Dipeptidyl Peptidase 4 Inhibitor [EPC]

Dipeptidyl Peptidase 4 Inhibitor [EPC] was reported 32611 times

Drugs of the Dipeptidyl Peptidase 4 Inhibitor [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 CARDIOSPASM 396 0.7097
1 IMMUNISATION 258 0.5945
2 PALMOPLANTAR KERATODERMA 391 0.5393
3 5-HYDROXYINDOLACETIC ACID INCREASED 20 0.3077
4 BLOOD MERCURY ABNORMAL 28 0.2857
5 URETHRAL CARUNCLE 18 0.2687
6 PULMONARY VALVE DISEASE 25 0.1923
7 ATRIAL TACHYCARDIA 398 0.1893
8 PRURITUS GENITAL 405 0.1718
9 HEPATOJUGULAR REFLUX 23 0.1386
10 CAROTID ARTERY OCCLUSION 403 0.1104
11 ELECTROCARDIOGRAM Q WAVE ABNORMAL 22 0.0940
12 SLEEP TERROR 390 0.0925
13 TENSION HEADACHE 394 0.0915
14 EUGLYCAEMIC DIABETIC KETOACIDOSIS 317 0.0767
15 MULTIPLE DRUG THERAPY 56 0.0743
16 PRODUCT MONITORING ERROR 98 0.0678
17 FIBROUS HISTIOCYTOMA 23 0.0655
18 NEUROLOGIC NEGLECT SYNDROME 36 0.0647
19 BLOOD FOLLICLE STIMULATING HORMONE INCREASED 23 0.0588
20 PHYSICAL EXAMINATION ABNORMAL 22 0.0574
21 PANCREATITIS HAEMORRHAGIC 26 0.0560
22 CAROTID ARTERY THROMBOSIS 44 0.0518
23 PEMPHIGOID 371 0.0491
24 OCCULT BLOOD 24 0.0457
25 SUBARACHNOID HAEMORRHAGE 465 0.0456
26 FACIAL PAIN 397 0.0444
27 INSULIN-LIKE GROWTH FACTOR DECREASED 23 0.0435
28 MILK-ALKALI SYNDROME 20 0.0382
29 EOSINOPHILIC MYOCARDITIS 27 0.0370
30 VASCULITIS 409 0.0351
31 DERMATITIS BULLOUS 247 0.0341
32 BALANOPOSTHITIS 27 0.0328
33 DIABETIC METABOLIC DECOMPENSATION 43 0.0310
34 BITE 20 0.0277
35 HYPERLACTACIDAEMIA 74 0.0276
36 ANOSMIA 399 0.0275
37 VENTRICULAR TACHYCARDIA 455 0.0275
38 ADJUSTMENT DISORDER 35 0.0269
39 GLYCOSYLATED HAEMOGLOBIN DECREASED 42 0.0261
40 KETOACIDOSIS 194 0.0259
41 CAROTID ARTERIOSCLEROSIS 26 0.0252
42 GLYCOSYLATED HAEMOGLOBIN ABNORMAL 30 0.0250
43 ATROPHIC VULVOVAGINITIS 18 0.0246
44 KETONURIA 20 0.0246
45 SYSTEMIC INFECTION 40 0.0241
46 PERICARDITIS 402 0.0239
47 LACTIC ACIDOSIS 771 0.0238
48 HELICOBACTER GASTRITIS 29 0.0234
49 DIABETIC KETOACIDOSIS 553 0.0230
50 DIABETES MELLITUS INADEQUATE CONTROL 386 0.0218
51 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 23 0.0217
52 HYPERGLYCAEMIC HYPEROSMOLAR NONKETOTIC SYNDROME 24 0.0216
53 NEPHROGENIC ANAEMIA 100 0.0216
54 LOW DENSITY LIPOPROTEIN DECREASED 30 0.0212
55 LEFT ATRIAL DILATATION 27 0.0212
56 PNEUMOCYSTIS JIROVECII INFECTION 25 0.0209
57 SYSTOLIC DYSFUNCTION 22 0.0209
58 LIGHT CHAIN ANALYSIS INCREASED 20 0.0194
59 HYPERPARATHYROIDISM SECONDARY 48 0.0191
60 GLYCOSYLATED HAEMOGLOBIN INCREASED 479 0.0190
61 GLOMERULONEPHRITIS MEMBRANOUS 22 0.0187
62 URINE KETONE BODY PRESENT 29 0.0184
63 RENAL TUBULAR ACIDOSIS 39 0.0179
64 MUSCLE TWITCHING 407 0.0176
65 HYPOVOLAEMIA 103 0.0176
66 APRAXIA 26 0.0175
67 HYPOGLYCAEMIA 827 0.0170
68 GLUCOSE URINE PRESENT 21 0.0165
69 ECHOCARDIOGRAM ABNORMAL 23 0.0164
70 DIABETIC NEPHROPATHY 35 0.0159
71 DIPLOPIA 413 0.0159
72 METABOLIC ACIDOSIS 495 0.0155
73 MUCOSAL DRYNESS 31 0.0154
74 PAIN OF SKIN 406 0.0151
75 HYPOGLYCAEMIC COMA 43 0.0149
76 SEDATION COMPLICATION 38 0.0149
77 HYPERKALAEMIA 519 0.0148
78 SUBSTANCE USE 23 0.0147
79 HYPERGLYCAEMIA 524 0.0144
80 STENOSIS 27 0.0144
81 LIP SWELLING 474 0.0142
82 CARDIAC DISCOMFORT 28 0.0139
83 TRANSIENT ISCHAEMIC ATTACK 465 0.0138
84 PERSONALITY DISORDER 36 0.0137
85 METABOLIC ALKALOSIS 22 0.0137
86 DIASTOLIC DYSFUNCTION 42 0.0136
87 NEOPLASM SKIN 21 0.0135
88 GANGRENE 81 0.0134
89 BLOOD GLUCOSE ABNORMAL 248 0.0134
90 RASH PAPULAR 299 0.0133
91 CAROTID ARTERY STENOSIS 46 0.0132
92 CLOSTRIDIUM TEST POSITIVE 29 0.0131
93 RALES 76 0.0131
94 RESPIRATORY ALKALOSIS 21 0.0129
95 PRERENAL FAILURE 18 0.0128
96 VENTRICULAR HYPOKINESIA 41 0.0128
97 DIABETIC FOOT 39 0.0127
98 VULVOVAGINAL MYCOTIC INFECTION 50 0.0127
99 LINEAR IGA DISEASE 21 0.0126
100 LEFT VENTRICULAR DYSFUNCTION 84 0.0125
101 POTENTIATING DRUG INTERACTION 42 0.0125
102 VITAMIN B12 DECREASED 36 0.0125
103 MITRAL VALVE DISEASE 22 0.0124
104 ANGIOEDEMA 548 0.0124
105 HYPOMAGNESAEMIA 172 0.0123
106 ABNORMAL LOSS OF WEIGHT 83 0.0122
107 EYE PRURITUS 408 0.0121
108 DIABETIC NEUROPATHY 60 0.0121
109 VENTRICULAR ARRHYTHMIA 44 0.0120
110 EXERCISE TOLERANCE DECREASED 69 0.0120
111 IMMUNE-MEDIATED MYOSITIS 33 0.0120
112 BLINDNESS 484 0.0119
113 ACUTE KIDNEY INJURY 1802 0.0118
114 ANAEMIA MACROCYTIC 25 0.0117
115 CHOLESTATIC LIVER INJURY 26 0.0117
116 BLOOD CHLORIDE DECREASED 30 0.0116
117 NECROTISING FASCIITIS 40 0.0113
118 BLOOD CHOLESTEROL DECREASED 21 0.0113
119 HYPOVOLAEMIC SHOCK 54 0.0113
120 BLOOD PRESSURE INADEQUATELY CONTROLLED 67 0.0111
121 BLOOD SODIUM INCREASED 30 0.0111
122 BLOOD PHOSPHORUS INCREASED 30 0.0110
123 HAEMATOCRIT INCREASED 25 0.0110
124 ELECTROCARDIOGRAM ABNORMAL 86 0.0109
125 COGNITIVE DISORDER 509 0.0109
126 BLOOD LACTIC ACID INCREASED 57 0.0108
127 MEAN CELL HAEMOGLOBIN CONCENTRATION DECREASED 18 0.0108
128 VITAMIN B12 DEFICIENCY 43 0.0106
129 GLOMERULAR FILTRATION RATE DECREASED 130 0.0106
130 DYSPNOEA AT REST 30 0.0103
131 PERICARDIAL HAEMORRHAGE 22 0.0101
132 BLOOD GLUCOSE INCREASED 1872 0.0099
133 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 87 0.0098
134 DYSLIPIDAEMIA 48 0.0094
135 PANCREATITIS ACUTE 209 0.0093
136 TINNITUS 427 0.0093
137 UROSEPSIS 85 0.0092
138 BUNDLE BRANCH BLOCK LEFT 39 0.0092
139 HEPATIC NEOPLASM 30 0.0092
140 END STAGE RENAL DISEASE 163 0.0089
141 AORTIC VALVE INCOMPETENCE 38 0.0089
142 PANCREATITIS 472 0.0089
143 REBOUND ACID HYPERSECRETION 27 0.0089
144 GASTRIC POLYPS 20 0.0088
145 DIABETIC RETINOPATHY 30 0.0088
146 DISTURBANCE IN ATTENTION 476 0.0088
147 NEUTROPHILIA 50 0.0088
148 TUBULOINTERSTITIAL NEPHRITIS 164 0.0087
149 AMYLASE INCREASED 32 0.0087
150 HAEMOGLOBIN INCREASED 39 0.0085
151 PHYSICAL DECONDITIONING 22 0.0085
152 WRONG PATIENT RECEIVED PRODUCT 25 0.0085
153 DRUG LEVEL ABOVE THERAPEUTIC 39 0.0085
154 POLYURIA 69 0.0084
155 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 34 0.0083
156 BLOOD PRESSURE DIASTOLIC ABNORMAL 21 0.0082
157 BLOOD PARATHYROID HORMONE INCREASED 24 0.0082
158 AMNESIA 535 0.0082
159 CARDIAC FAILURE CHRONIC 35 0.0082
160 ARTERIAL OCCLUSIVE DISEASE 64 0.0081
161 PROTEIN URINE PRESENT 40 0.0080
162 ARTERIOSCLEROSIS CORONARY ARTERY 53 0.0080
163 MONOCYTE COUNT INCREASED 29 0.0080
164 PANCREATITIS NECROTISING 18 0.0078
165 AZOTAEMIA 31 0.0078
166 ACIDOSIS 59 0.0077
167 INTRAVENTRICULAR HAEMORRHAGE 19 0.0076
168 CHRONIC KIDNEY DISEASE 577 0.0076
169 BILE DUCT STONE 24 0.0075
170 GASTROINTESTINAL HYPOMOTILITY 17 0.0075
171 DISTRIBUTIVE SHOCK 17 0.0075
172 NEPHROPATHY 69 0.0074
173 CORONARY ARTERY STENOSIS 37 0.0074
174 TACHYCARDIA 651 0.0073
175 DEHYDRATION 969 0.0073
176 LEG AMPUTATION 29 0.0070
177 BLOOD CREATINE INCREASED 31 0.0070
178 TOE AMPUTATION 35 0.0069
179 HALLUCINATION 518 0.0069
180 PYELONEPHRITIS 59 0.0068
181 LEFT VENTRICULAR HYPERTROPHY 29 0.0068
182 RED CELL DISTRIBUTION WIDTH INCREASED 28 0.0067
183 ELECTROLYTE IMBALANCE 78 0.0067
184 TOXIC ENCEPHALOPATHY 34 0.0067
185 RESPIRATORY SYMPTOM 19 0.0067
186 TRICUSPID VALVE INCOMPETENCE 53 0.0067
187 METABOLIC ENCEPHALOPATHY 20 0.0067
188 PEPTIC ULCER 22 0.0066
189 POLYDIPSIA 26 0.0066
190 DYSAESTHESIA 20 0.0065
191 LIPASE INCREASED 50 0.0065
192 OESOPHAGEAL CANDIDIASIS 26 0.0065
193 MUSCULAR WEAKNESS 731 0.0064
194 HAEMODYNAMIC INSTABILITY 49 0.0064
195 CARDIOMEGALY 79 0.0064
196 DRUG LEVEL INCREASED 106 0.0064
197 ANTIPSYCHOTIC DRUG LEVEL INCREASED 18 0.0064
198 TESTICULAR PAIN 20 0.0063
199 BLOOD GLUCOSE FLUCTUATION 69 0.0063
200 URINE OUTPUT DECREASED 55 0.0063
201 BLOOD PRESSURE DIASTOLIC INCREASED 29 0.0063
202 ORTHOPNOEA 20 0.0063
203 ACUTE MYOCARDIAL INFARCTION 185 0.0063
204 RENAL IMPAIRMENT 526 0.0063
205 IMPAIRED GASTRIC EMPTYING 85 0.0062
206 HYPERNATRAEMIA 31 0.0062
207 HEMIPLEGIA 51 0.0061
208 BLOOD UREA INCREASED 102 0.0061
209 TACHYPNOEA 82 0.0060
210 SPUTUM DISCOLOURED 57 0.0060
211 MIXED LIVER INJURY 18 0.0060
212 SENSORY LOSS 48 0.0060
213 SHOCK 137 0.0060
214 CLOSTRIDIUM DIFFICILE COLITIS 63 0.0059
215 ANURIA 51 0.0059
216 CARDIAC DYSFUNCTION 22 0.0059
217 IMMUNE THROMBOCYTOPENIA 27 0.0059
218 MELAENA 129 0.0059
219 GENERAL PHYSICAL HEALTH DETERIORATION 675 0.0058
220 ATRIOVENTRICULAR BLOCK 45 0.0058
221 ATRIOVENTRICULAR BLOCK FIRST DEGREE 25 0.0058
222 UPPER GASTROINTESTINAL HAEMORRHAGE 97 0.0058
223 SUSPECTED SUICIDE 27 0.0058
224 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 19 0.0057
225 DERMATITIS EXFOLIATIVE GENERALISED 20 0.0057
226 SUPRAVENTRICULAR TACHYCARDIA 55 0.0057
227 ANGIOPATHY 32 0.0057
228 PALPITATIONS 667 0.0057
229 STAPHYLOCOCCAL SEPSIS 28 0.0057
230 PERIPHERAL ISCHAEMIA 23 0.0056
231 DRUG LEVEL BELOW THERAPEUTIC 31 0.0056
232 RENAL TUBULAR NECROSIS 55 0.0056
233 STUPOR 18 0.0056
234 HYPERURICAEMIA 23 0.0056
235 BLOOD PRESSURE SYSTOLIC INCREASED 109 0.0056
236 BLOOD PRESSURE DIASTOLIC DECREASED 41 0.0055
237 BLOOD POTASSIUM INCREASED 90 0.0055
238 DUODENITIS 17 0.0055
239 LEUKOCYTOSIS 100 0.0055
240 INTENTIONAL PRODUCT MISUSE 483 0.0055
241 ACUTE RESPIRATORY FAILURE 106 0.0055
242 PULSELESS ELECTRICAL ACTIVITY 23 0.0055
243 PRODUCT PRESCRIBING ERROR 130 0.0055
244 ACUTE CORONARY SYNDROME 45 0.0054
245 ORTHOSTATIC HYPOTENSION 94 0.0054
246 NOCTURIA 65 0.0053
247 HEART RATE INCREASED 529 0.0053
248 HAEMORRHOIDAL HAEMORRHAGE 26 0.0053
249 THIRST 95 0.0053
250 BLOOD GLUCOSE DECREASED 255 0.0053
251 MOTOR DYSFUNCTION 54 0.0053
252 INCONTINENCE 56 0.0053
253 RHABDOMYOLYSIS 220 0.0053
254 PROTEINURIA 100 0.0053
255 SUBCUTANEOUS ABSCESS 25 0.0052
256 ODYNOPHAGIA 31 0.0052
257 RENAL FAILURE 689 0.0052
258 OLIGURIA 32 0.0051
259 DIABETES MELLITUS 391 0.0051
260 PARKINSONISM 50 0.0051
261 FULL BLOOD COUNT ABNORMAL 54 0.0051
262 MYOPATHY 44 0.0051
263 AFFECT LABILITY 49 0.0051
264 PROSTATOMEGALY 20 0.0051
265 DELIRIUM 176 0.0051
266 IDIOPATHIC PULMONARY FIBROSIS 20 0.0051
267 ORGANISING PNEUMONIA 25 0.0050
268 MITRAL VALVE INCOMPETENCE 57 0.0050
269 INTENTIONAL PRODUCT USE ISSUE 439 0.0050
270 NEUTROPHIL COUNT INCREASED 51 0.0050
271 PERIPHERAL SWELLING 767 0.0050
272 BLOOD CREATININE INCREASED 325 0.0050
273 FUNGAL INFECTION 164 0.0049
274 HYPONATRAEMIA 277 0.0049
275 BLOOD CREATININE ABNORMAL 17 0.0049
276 CARDIAC FAILURE 386 0.0048
277 HYPOCALCAEMIA 91 0.0048
278 FLANK PAIN 45 0.0048
279 DRUG INTERACTION 761 0.0048
280 MEDICATION ERROR 266 0.0048
281 FAECALOMA 26 0.0047
282 VISUAL IMPAIRMENT 588 0.0047
283 HYPERHIDROSIS 610 0.0047
284 HYPOPHAGIA 121 0.0047
285 GASTRITIS EROSIVE 22 0.0047
286 SEPTIC SHOCK 204 0.0047
287 CHOLANGITIS 29 0.0047
288 BLOOD THYROID STIMULATING HORMONE INCREASED 43 0.0047
289 ONYCHOCLASIS 32 0.0046
290 PANCREATIC CARCINOMA 134 0.0046
291 HAEMATOCRIT DECREASED 92 0.0046
292 BLOOD IRON DECREASED 55 0.0046
293 NEUTROPENIC SEPSIS 33 0.0046
294 MIGRAINE 441 0.0046
295 FAECES DISCOLOURED 100 0.0046
296 EJECTION FRACTION DECREASED 71 0.0046
297 ABDOMINAL DISCOMFORT 761 0.0045
298 NEPHROTIC SYNDROME 31 0.0045
299 METABOLIC DISORDER 26 0.0045
300 ARTERIOSCLEROSIS 42 0.0045
301 ANGINA UNSTABLE 29 0.0045
302 BLOOD TRIGLYCERIDES INCREASED 78 0.0044
303 URINE ABNORMALITY 20 0.0044
304 ANGINA PECTORIS 126 0.0044
305 ASPIRATION 48 0.0044
306 OEDEMA PERIPHERAL 534 0.0044
307 GOUT 78 0.0043
308 COVID-19 PNEUMONIA 51 0.0043
309 HYPERLIPIDAEMIA 51 0.0043
310 PANCREATIC DISORDER 21 0.0043
311 FAILURE TO THRIVE 22 0.0042
312 MEMORY IMPAIRMENT 580 0.0042
313 LOWER GASTROINTESTINAL HAEMORRHAGE 31 0.0042
314 CARDIOGENIC SHOCK 60 0.0042
315 EOSINOPHILIA 73 0.0042
316 ASPHYXIA 34 0.0042
317 OBSTRUCTIVE AIRWAYS DISORDER 46 0.0041
318 NECROSIS 23 0.0041
319 HAEMATOCHEZIA 228 0.0041
320 TYPE 2 DIABETES MELLITUS 139 0.0041
321 BREAST CANCER METASTATIC 44 0.0041
322 CHEST PAIN 758 0.0041
323 COVID-19 717 0.0041
324 HEPATIC STEATOSIS 76 0.0041
325 BODY TEMPERATURE DECREASED 40 0.0041
326 SPRUE-LIKE ENTEROPATHY 20 0.0041
327 CARDIAC FAILURE ACUTE 27 0.0040
328 BRADYCARDIA 215 0.0040
329 SHOCK HAEMORRHAGIC 33 0.0040
330 CONCOMITANT DISEASE AGGRAVATED 25 0.0040
331 HYPERVOLAEMIA 20 0.0040
332 BLOOD ALBUMIN DECREASED 32 0.0040
333 MUSCLE RIGIDITY 48 0.0040
334 COLITIS MICROSCOPIC 19 0.0040
335 HYDRONEPHROSIS 30 0.0040
336 MYOCARDIAL INFARCTION 699 0.0040
337 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 41 0.0040
338 HAEMATEMESIS 101 0.0040
339 GASTROENTERITIS 58 0.0040
340 ABDOMINAL PAIN UPPER 818 0.0040
341 ALTERED STATE OF CONSCIOUSNESS 86 0.0040
342 BACTERAEMIA 47 0.0040
343 BLOOD PRESSURE SYSTOLIC DECREASED 18 0.0040
344 POST PROCEDURAL INFECTION 32 0.0039
345 RENAL DISORDER 183 0.0039
346 HYPOPHOSPHATAEMIA 29 0.0039
347 SINUS CONGESTION 53 0.0039
348 DYSURIA 143 0.0039
349 CHOLECYSTITIS ACUTE 22 0.0039
350 ADRENAL INSUFFICIENCY 47 0.0039
351 FACIAL PARALYSIS 33 0.0039
352 PULMONARY CONGESTION 51 0.0039
353 PERICARDIAL EFFUSION 89 0.0038
354 INFARCTION 26 0.0038
355 NEUROLEPTIC MALIGNANT SYNDROME 45 0.0038
356 IRON DEFICIENCY ANAEMIA 35 0.0038
357 JAUNDICE 102 0.0038
358 LYMPHOCYTE COUNT DECREASED 67 0.0038
359 ERYSIPELAS 19 0.0038
360 CYSTITIS 120 0.0038
361 DEPRESSED LEVEL OF CONSCIOUSNESS 149 0.0038
362 HYPERTRIGLYCERIDAEMIA 22 0.0038
363 KIDNEY TRANSPLANT REJECTION 18 0.0037
364 PALLOR 102 0.0037
365 DRY SKIN 499 0.0037
366 RESPIRATORY RATE INCREASED 33 0.0037
367 TORSADE DE POINTES 29 0.0037
368 CYTOKINE RELEASE SYNDROME 74 0.0037
369 UNRESPONSIVE TO STIMULI 95 0.0037
370 INTERNAL HAEMORRHAGE 42 0.0037
371 HYPERTHERMIA 28 0.0037
372 COORDINATION ABNORMAL 51 0.0037
373 TYPE 1 DIABETES MELLITUS 22 0.0036
374 HAEMATURIA 125 0.0036
375 BLOOD URIC ACID INCREASED 21 0.0036
376 POLLAKIURIA 151 0.0036
377 CEREBRAL INFARCTION 88 0.0036
378 HEMIPARESIS 61 0.0036
379 SYNCOPE 358 0.0036
380 HYPERBILIRUBINAEMIA 37 0.0036
381 CHOLELITHIASIS 117 0.0036
382 GAMMA-GLUTAMYLTRANSFERASE INCREASED 79 0.0036
383 VULVOVAGINAL PRURITUS 18 0.0036
384 ANAEMIA 675 0.0035
385 SKIN ULCER 91 0.0035
386 C-REACTIVE PROTEIN INCREASED 128 0.0035
387 BLOOD CREATINE PHOSPHOKINASE INCREASED 101 0.0035
388 DRUG-INDUCED LIVER INJURY 110 0.0035
389 BLOOD SODIUM DECREASED 66 0.0035
390 PNEUMOCYSTIS JIROVECII PNEUMONIA 35 0.0035
391 URINARY TRACT INFECTION 591 0.0035
392 CHOLECYSTITIS 41 0.0034
393 ATRIAL FIBRILLATION 335 0.0034
394 CONTRAINDICATED PRODUCT ADMINISTERED 104 0.0034
395 GASTRIC ULCER HAEMORRHAGE 19 0.0034
396 RED BLOOD CELL COUNT DECREASED 98 0.0034
397 DUODENAL ULCER 24 0.0034
398 NEPHROPATHY TOXIC 38 0.0034
399 HYPOTENSION 676 0.0034
400 PULMONARY MASS 50 0.0034
401 URINARY INCONTINENCE 99 0.0033
402 RESPIRATORY TRACT CONGESTION 53 0.0033
403 HAEMORRHOIDS 65 0.0033
404 VOMITING 1565 0.0033
405 LETHARGY 191 0.0033
406 DECUBITUS ULCER 27 0.0033
407 DIALYSIS 47 0.0033
408 HYPOKALAEMIA 152 0.0033
409 ATRIOVENTRICULAR BLOCK COMPLETE 22 0.0033
410 ATAXIA 39 0.0033
411 AGRANULOCYTOSIS 61 0.0033
412 DISSEMINATED INTRAVASCULAR COAGULATION 46 0.0033
413 SCIATICA 52 0.0033
414 INTERNATIONAL NORMALISED RATIO INCREASED 93 0.0033
415 CARDIOMYOPATHY 48 0.0032
416 HYPERCALCAEMIA 40 0.0032
417 BACK PAIN 752 0.0032
418 LOW DENSITY LIPOPROTEIN INCREASED 25 0.0032
419 DYSARTHRIA 121 0.0032
420 ATELECTASIS 31 0.0032
421 DIZZINESS POSTURAL 31 0.0032
422 EATING DISORDER 68 0.0032
423 HEART RATE IRREGULAR 72 0.0032
424 SKIN HAEMORRHAGE 47 0.0032
425 ELECTROCARDIOGRAM QT PROLONGED 114 0.0032
426 HYPOKINESIA 46 0.0032
427 PNEUMONIA BACTERIAL 29 0.0032
428 BLOOD POTASSIUM DECREASED 95 0.0032
429 TROPONIN INCREASED 24 0.0032
430 SUBDURAL HAEMATOMA 45 0.0031
431 CORONARY ARTERY DISEASE 95 0.0031
432 DIARRHOEA 2023 0.0031
433 PYREXIA 1083 0.0031
434 SEPSIS 349 0.0031
435 CATARACT 186 0.0031
436 MOUTH SWELLING 18 0.0031
437 ENTEROCOLITIS 18 0.0031
438 WRONG PRODUCT ADMINISTERED 21 0.0031
439 CONCUSSION 24 0.0031
440 HAEMOGLOBIN DECREASED 318 0.0031
441 MUSCLE SPASTICITY 38 0.0031
442 POOR VENOUS ACCESS 32 0.0031
443 HAEMATOMA 80 0.0031
444 THROMBOTIC MICROANGIOPATHY 30 0.0031
445 NERVE INJURY 34 0.0031
446 CONFUSIONAL STATE 494 0.0031
447 ASPERGILLUS INFECTION 20 0.0030
448 HEPATOCELLULAR CARCINOMA 23 0.0030
449 RENAL PAIN 32 0.0030
450 ALOPECIA 592 0.0030
451 CARDIAC MURMUR 26 0.0030
452 ERYTHEMA MULTIFORME 28 0.0030
453 HEPATIC ENCEPHALOPATHY 28 0.0030
454 BLOOD PRESSURE FLUCTUATION 72 0.0030
455 RENAL INJURY 89 0.0030
456 BLOOD PRESSURE DECREASED 199 0.0030
457 TOXIC EPIDERMAL NECROLYSIS 45 0.0030
458 PNEUMONIA ASPIRATION 74 0.0030
459 NEOPLASM 34 0.0030
460 FALL 983 0.0030
461 INTERSTITIAL LUNG DISEASE 143 0.0030
462 DISORIENTATION 117 0.0029
463 RETINAL HAEMORRHAGE 21 0.0029
464 INTESTINAL OBSTRUCTION 111 0.0029
465 GASTROINTESTINAL INFLAMMATION 23 0.0029
466 CIRCULATORY COLLAPSE 50 0.0029
467 MULTIPLE ORGAN DYSFUNCTION SYNDROME 83 0.0029
468 CELLULITIS 147 0.0029
469 BRADYPHRENIA 19 0.0029
470 PULMONARY OEDEMA 130 0.0029
471 PNEUMONITIS 79 0.0029
472 DIZZINESS 1447 0.0029
473 FEBRILE NEUTROPENIA 192 0.0029
474 ABDOMINAL PAIN 670 0.0029
475 EOSINOPHIL COUNT INCREASED 24 0.0029
476 PEMPHIGUS 36 0.0029
477 OSTEOMYELITIS 52 0.0029
478 DECREASED APPETITE 665 0.0029
479 DYSPNOEA 1620 0.0029
480 POLYNEUROPATHY 34 0.0028
481 SLEEP APNOEA SYNDROME 54 0.0028
482 DEMENTIA 79 0.0028
483 GASTROINTESTINAL HAEMORRHAGE 236 0.0028
484 WEIGHT DECREASED 788 0.0028
485 SPINAL PAIN 33 0.0028
486 TREATMENT NONCOMPLIANCE 154 0.0028
487 ORAL CANDIDIASIS 37 0.0028
488 CLOSTRIDIUM DIFFICILE INFECTION 61 0.0028
489 PLEURAL EFFUSION 170 0.0028
490 RECTAL HAEMORRHAGE 120 0.0028
491 PULMONARY HYPERTENSION 58 0.0028
492 ANAL INCONTINENCE 25 0.0028
493 TOXICITY TO VARIOUS AGENTS 468 0.0028
494 EYE HAEMORRHAGE 37 0.0028
495 RENAL CYST 22 0.0028
496 DRUG ERUPTION 49 0.0028
497 PLATELET COUNT INCREASED 36 0.0028
498 GENERALISED OEDEMA 34 0.0027
499 HAEMODIALYSIS 23 0.0027
500 DYSPNOEA EXERTIONAL 103 0.0027
501 FEELING ABNORMAL 655 0.0027
502 GROIN PAIN 24 0.0027
503 OEDEMA 148 0.0027
504 SINUS DISORDER 54 0.0027
505 HYPOXIA 96 0.0027
506 BLINDNESS TRANSIENT 20 0.0027
507 SUBSTANCE ABUSE 22 0.0027
508 SKIN LESION 74 0.0027
509 SWOLLEN TONGUE 84 0.0027
510 APHASIA 81 0.0027
511 CARDIAC OPERATION 23 0.0027
512 ENTERITIS 17 0.0027
513 MUSCULOSKELETAL CHEST PAIN 41 0.0026
514 HAEMOGLOBIN ABNORMAL 17 0.0026
515 NEPHROLITHIASIS 121 0.0026
516 ACUTE HEPATIC FAILURE 36 0.0026
517 ATRIAL SEPTAL DEFECT 22 0.0026
518 CARDIAC FAILURE CONGESTIVE 211 0.0026
519 HEAD INJURY 83 0.0026
520 PERIPHERAL COLDNESS 36 0.0026
521 MOVEMENT DISORDER 84 0.0026
522 BLOOD PRESSURE ABNORMAL 52 0.0026
523 MALAISE 1147 0.0026
524 VENTRICULAR FIBRILLATION 29 0.0026
525 GASTROOESOPHAGEAL REFLUX DISEASE 210 0.0026
526 WHITE BLOOD CELL COUNT INCREASED 100 0.0026
527 LUNG INFILTRATION 23 0.0026
528 PURPURA 23 0.0026
529 KIDNEY INFECTION 51 0.0026
530 HUNGER 36 0.0026
531 BRONCHOPULMONARY ASPERGILLOSIS 20 0.0026
532 GASTRIC ULCER 49 0.0026
533 URINARY RETENTION 86 0.0026
534 PRURITUS 984 0.0026
535 INSOMNIA 679 0.0025
536 MUSCULOSKELETAL PAIN 133 0.0025
537 PHARYNGEAL OEDEMA 39 0.0025
538 DEPRESSED MOOD 134 0.0025
539 MOBILITY DECREASED 182 0.0025
540 EPISTAXIS 188 0.0025
541 GASTROINTESTINAL DISORDER 225 0.0025
542 BLISTER 141 0.0025
543 TOXIC SKIN ERUPTION 25 0.0025
544 PNEUMONIA 802 0.0025
545 HIATUS HERNIA 32 0.0025
546 ARRHYTHMIA 117 0.0025
547 RESPIRATORY FAILURE 180 0.0025
548 SINUS TACHYCARDIA 35 0.0025
549 FOOD ALLERGY 19 0.0025
550 SKIN DISORDER 82 0.0025
551 GAIT INABILITY 82 0.0025
552 CHOLESTASIS 47 0.0024
553 NAUSEA 1937 0.0024
554 HYPERTENSION 518 0.0024
555 DYSPHAGIA 231 0.0024
556 BLOOD MAGNESIUM DECREASED 21 0.0024
557 PSYCHOLOGICAL TRAUMA 21 0.0024
558 WOUND 68 0.0024
559 FRACTURE 46 0.0024
560 WHEEZING 144 0.0024
561 HYPERTENSIVE CRISIS 27 0.0024
562 DEFAECATION URGENCY 17 0.0024
563 LIMB DISCOMFORT 75 0.0024
564 BLOOD PRESSURE INCREASED 370 0.0024
565 ANXIETY 688 0.0024
566 TASTE DISORDER 49 0.0024
567 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 23 0.0024
568 PRODUCTIVE COUGH 115 0.0024
569 CYTOMEGALOVIRUS INFECTION 40 0.0024
570 HYPOTONIA 24 0.0024
571 DIVERTICULUM 17 0.0024
572 CARDIO-RESPIRATORY ARREST 100 0.0024
573 ARTHRALGIA 994 0.0024
574 NERVE COMPRESSION 22 0.0024
575 ASTHENIA 896 0.0024
576 MYOCARDIAL ISCHAEMIA 27 0.0024
577 HEPATIC FUNCTION ABNORMAL 88 0.0024
578 CONSTIPATION 514 0.0024
579 GASTRITIS 62 0.0024
580 MYOCLONUS 28 0.0023
581 CHROMATURIA 53 0.0023
582 PRESYNCOPE 57 0.0023
583 MALNUTRITION 26 0.0023
584 CARDIAC ARREST 191 0.0023
585 FLATULENCE 131 0.0023
586 ESCHERICHIA INFECTION 19 0.0023
587 BLOOD COUNT ABNORMAL 35 0.0023
588 INCORRECT PRODUCT ADMINISTRATION DURATION 50 0.0023
589 INTENTIONAL OVERDOSE 147 0.0023
590 OESOPHAGITIS 25 0.0023
591 RETINAL DETACHMENT 21 0.0023
592 NEUROTOXICITY 40 0.0023
593 PRESCRIBED OVERDOSE 44 0.0023
594 HYPOTHERMIA 23 0.0023
595 BLINDNESS UNILATERAL 32 0.0023
596 RESPIRATORY TRACT INFECTION 59 0.0023
597 BLOOD URINE PRESENT 43 0.0023
598 BALANCE DISORDER 195 0.0023
599 BLOOD CHOLESTEROL INCREASED 105 0.0023
600 ACUTE MYELOID LEUKAEMIA 35 0.0022
601 RHINORRHOEA 145 0.0022
602 ENCEPHALOPATHY 55 0.0022
603 SCHIZOPHRENIA 27 0.0022
604 COLD SWEAT 39 0.0022
605 BLOOD LACTATE DEHYDROGENASE INCREASED 35 0.0022
606 ASPARTATE AMINOTRANSFERASE INCREASED 117 0.0022
607 SALIVARY HYPERSECRETION 22 0.0022
608 HICCUPS 18 0.0022
609 FATIGUE 1705 0.0022
610 SOPOR 29 0.0022
611 ORAL PAIN 49 0.0022
612 ILEUS 27 0.0022
613 OSTEOPOROSIS 89 0.0022
614 JOINT INJURY 46 0.0022
615 OXYGEN SATURATION DECREASED 121 0.0022
616 HYPERTHYROIDISM 31 0.0021
617 SQUAMOUS CELL CARCINOMA 20 0.0021
618 GINGIVAL BLEEDING 29 0.0021
619 LYMPHOPENIA 30 0.0021
620 CORONARY ARTERY OCCLUSION 29 0.0021
621 RASH MACULO-PAPULAR 47 0.0021
622 CHEST DISCOMFORT 216 0.0021
623 GASTROENTERITIS VIRAL 38 0.0021
624 ADVERSE DRUG REACTION 189 0.0021
625 OROPHARYNGEAL DISCOMFORT 19 0.0021
626 CEREBROVASCULAR ACCIDENT 355 0.0021
627 SNEEZING 47 0.0021
628 PANCYTOPENIA 117 0.0021
629 HYPOACUSIS 90 0.0021
630 METASTASES TO LUNG 24 0.0021
631 HEPATIC CIRRHOSIS 39 0.0021
632 CANDIDA INFECTION 35 0.0021
633 BREAST PAIN 22 0.0021
634 LOSS OF CONSCIOUSNESS 264 0.0021
635 COLITIS 78 0.0021
636 LOWER RESPIRATORY TRACT INFECTION 93 0.0020
637 AGEUSIA 51 0.0020
638 CONTUSION 196 0.0020
639 DRUG PRESCRIBING ERROR 39 0.0020
640 LIMB INJURY 55 0.0020
641 COMPLETED SUICIDE 168 0.0020
642 ERUCTATION 39 0.0020
643 ANKLE FRACTURE 31 0.0020
644 COUGH 556 0.0020
645 SEASONAL ALLERGY 28 0.0020
646 HYPOTHYROIDISM 63 0.0020
647 MYALGIA 335 0.0020
648 HEPATIC CYTOLYSIS 25 0.0020
649 VISUAL ACUITY REDUCED 65 0.0020
650 METASTASES TO BONE 32 0.0019
651 DECREASED ACTIVITY 21 0.0019
652 OBESITY 31 0.0019
653 LOCALISED INFECTION 47 0.0019
654 BLOOD CALCIUM INCREASED 17 0.0019
655 ABDOMINAL PAIN LOWER 49 0.0019
656 PHARYNGITIS 24 0.0019
657 WEIGHT INCREASED 433 0.0019
658 CEREBRAL HAEMORRHAGE 69 0.0019
659 FLUID RETENTION 98 0.0019
660 BLOOD BILIRUBIN INCREASED 52 0.0019
661 NEUROPATHY PERIPHERAL 183 0.0019
662 HEPATIC FAILURE 58 0.0019
663 THROMBOCYTOPENIA 215 0.0019
664 TENDERNESS 20 0.0019
665 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 100 0.0019
666 ASCITES 56 0.0019
667 HAEMOPTYSIS 53 0.0019
668 STEVENS-JOHNSON SYNDROME 42 0.0019
669 ACCIDENTAL OVERDOSE 69 0.0019
670 ULCER 30 0.0019
671 PRODUCT ADMINISTRATION ERROR 38 0.0019
672 RETCHING 40 0.0019
673 ROTATOR CUFF SYNDROME 24 0.0019
674 PLATELET COUNT DECREASED 199 0.0019
675 ACUTE RESPIRATORY DISTRESS SYNDROME 33 0.0019
676 INFUSION SITE PAIN 24 0.0019
677 ABDOMINAL DISTENSION 194 0.0019
678 LIVER FUNCTION TEST ABNORMAL 54 0.0019
679 MOUTH ULCERATION 39 0.0018
680 ISCHAEMIC STROKE 33 0.0018
681 VITAMIN D DEFICIENCY 18 0.0018
682 LEUKOPENIA 92 0.0018
683 GAIT DISTURBANCE 352 0.0018
684 OSTEOARTHRITIS 77 0.0018
685 RESTLESS LEGS SYNDROME 33 0.0018
686 HEADACHE 1137 0.0018
687 TRANSFUSION 19 0.0018
688 SCAR 31 0.0018
689 CONDITION AGGRAVATED 549 0.0018
690 PRESCRIBED UNDERDOSE 36 0.0018
691 PRURITUS GENERALISED 39 0.0018
692 PULMONARY EMBOLISM 171 0.0018
693 JOINT DISLOCATION 19 0.0018
694 OROPHARYNGEAL PAIN 166 0.0018
695 SMALL INTESTINAL OBSTRUCTION 22 0.0018
696 PAIN IN EXTREMITY 522 0.0018
697 LIVER FUNCTION TEST INCREASED 38 0.0018
698 JOINT SWELLING 212 0.0018
699 SOMNOLENCE 352 0.0017
700 MYOCARDITIS 20 0.0017
701 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 124 0.0017
702 RASH GENERALISED 45 0.0017
703 MUSCLE ATROPHY 22 0.0017
704 DIVERTICULITIS 48 0.0017
705 RASH 751 0.0017
706 HOSPICE CARE 17 0.0017
707 WEIGHT FLUCTUATION 18 0.0017
708 RASH PRURITIC 93 0.0017
709 DYSSTASIA 50 0.0017
710 SUDDEN DEATH 18 0.0017
711 RASH ERYTHEMATOUS 81 0.0017
712 TREMOR 281 0.0017
713 ALANINE AMINOTRANSFERASE INCREASED 103 0.0017
714 LIVER INJURY 41 0.0017
715 WRIST FRACTURE 20 0.0017
716 UPPER RESPIRATORY TRACT INFECTION 77 0.0017
717 POST PROCEDURAL COMPLICATION 32 0.0017
718 MYELODYSPLASTIC SYNDROME 24 0.0017
719 SWELLING FACE 108 0.0017
720 OFF LABEL USE 1448 0.0017
721 ABSCESS 26 0.0016
722 SINUSITIS 167 0.0016
723 LABORATORY TEST ABNORMAL 48 0.0016
724 RENAL FAILURE ACUTE 69 0.0016
725 DEVICE RELATED INFECTION 25 0.0016
726 BRONCHITIS 120 0.0016
727 MUSCULOSKELETAL STIFFNESS 142 0.0016
728 BODY TEMPERATURE INCREASED 33 0.0016
729 HEPATOTOXICITY 36 0.0016
730 DYSPEPSIA 159 0.0016
731 PULMONARY FIBROSIS 31 0.0016
732 ARTHRITIS 127 0.0016
733 SKIN EXFOLIATION 136 0.0016
734 CYST 20 0.0016
735 BACTERIAL INFECTION 30 0.0016
736 PAIN 986 0.0016
737 RIB FRACTURE 33 0.0016
738 DRY MOUTH 130 0.0016
739 BLOOD CALCIUM DECREASED 18 0.0016
740 PROSTATIC SPECIFIC ANTIGEN INCREASED 22 0.0016
741 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 41 0.0016
742 METASTASES TO LIVER 28 0.0016
743 DERMATITIS ALLERGIC 20 0.0016
744 INFLUENZA 177 0.0016
745 ASTHMA 179 0.0016
746 FEEDING DISORDER 32 0.0016
747 LUNG DISORDER 77 0.0016
748 SKIN DISCOLOURATION 72 0.0016
749 VERTIGO 95 0.0016
750 ANAPHYLACTIC SHOCK 40 0.0015
751 FEELING COLD 43 0.0015
752 COLON CANCER 23 0.0015
753 BURNING SENSATION 108 0.0015
754 NECK PAIN 86 0.0015
755 INFLAMMATION 79 0.0015
756 DERMATITIS 32 0.0015
757 ERECTILE DYSFUNCTION 39 0.0015
758 HALLUCINATION, VISUAL 32 0.0015
759 GLAUCOMA 29 0.0015
760 NEUTROPHIL COUNT DECREASED 61 0.0015
761 URTICARIA 250 0.0015
762 RESPIRATORY DISTRESS 41 0.0015
763 HEPATITIS 38 0.0015
764 GASTRIC HAEMORRHAGE 17 0.0015
765 FOOT FRACTURE 28 0.0015
766 INTERVERTEBRAL DISC PROTRUSION 32 0.0015
767 VISION BLURRED 200 0.0015
768 UPPER LIMB FRACTURE 29 0.0015
769 PRODUCT USE ISSUE 273 0.0015
770 HEART RATE DECREASED 51 0.0015
771 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 261 0.0014
772 SPINAL FRACTURE 29 0.0014
773 EXPIRED PRODUCT ADMINISTERED 48 0.0014
774 POISONING 18 0.0014
775 NASAL CONGESTION 84 0.0014
776 SLEEP DISORDER 100 0.0014
777 DELUSION 22 0.0014
778 EXTRAPYRAMIDAL DISORDER 35 0.0014
779 DYSKINESIA 57 0.0014
780 WHITE BLOOD CELL COUNT DECREASED 152 0.0014
781 GALLBLADDER DISORDER 25 0.0014
782 MUSCLE SPASMS 256 0.0014
783 MUSCULOSKELETAL DISCOMFORT 24 0.0014
784 GENERALISED TONIC-CLONIC SEIZURE 23 0.0014
785 PNEUMOTHORAX 22 0.0014
786 ECONOMIC PROBLEM 21 0.0014
787 CHOKING 27 0.0014
788 NEUTROPENIA 188 0.0014
789 COAGULOPATHY 23 0.0014
790 PULMONARY ARTERIAL HYPERTENSION 20 0.0014
791 INJECTION SITE MASS 51 0.0014
792 PRODUCT DISPENSING ERROR 30 0.0014
793 LIVER DISORDER 61 0.0014
794 BLOOD ALKALINE PHOSPHATASE INCREASED 34 0.0014
795 MENTAL STATUS CHANGES 38 0.0014
796 FEELING JITTERY 26 0.0014
797 FACE OEDEMA 23 0.0014
798 PSYCHOTIC DISORDER 40 0.0014
799 CHILLS 157 0.0013
800 INFLUENZA LIKE ILLNESS 110 0.0013
801 DYSGEUSIA 98 0.0013
802 NASOPHARYNGITIS 243 0.0013
803 SWELLING 123 0.0013
804 HYPOAESTHESIA 196 0.0013
805 RESPIRATORY ARREST 36 0.0013
806 STAPHYLOCOCCAL INFECTION 43 0.0013
807 ILLNESS 134 0.0013
808 INFECTION 188 0.0013
809 MUSCLE TIGHTNESS 21 0.0013
810 THROAT TIGHTNESS 35 0.0013
811 FEMUR FRACTURE 40 0.0013
812 EAR PAIN 25 0.0013
813 CARPAL TUNNEL SYNDROME 18 0.0013
814 GASTRIC DISORDER 44 0.0013
815 AGGRESSION 64 0.0013
816 EYE PAIN 72 0.0013
817 DYSPHONIA 74 0.0013
818 EYE SWELLING 47 0.0013
819 DRUG INTOLERANCE 122 0.0013
820 CARDIAC DISORDER 118 0.0013
821 INCREASED APPETITE 24 0.0013
822 PERITONITIS 26 0.0013
823 OSTEOPENIA 19 0.0013
824 HEAD DISCOMFORT 22 0.0012
825 NIGHTMARE 43 0.0012
826 EAR INFECTION 33 0.0012
827 COMA 59 0.0012
828 HERPES ZOSTER 71 0.0012
829 KNEE ARTHROPLASTY 26 0.0012
830 THYROID DISORDER 19 0.0012
831 RESTLESSNESS 45 0.0012
832 ORAL HERPES 24 0.0012
833 SEIZURE 142 0.0012
834 FREQUENT BOWEL MOVEMENTS 33 0.0012
835 STOMATITIS 74 0.0012
836 PARAESTHESIA 191 0.0012
837 ERYTHEMA 249 0.0012
838 ECZEMA 63 0.0012
839 THERAPEUTIC RESPONSE UNEXPECTED 54 0.0012
840 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 57 0.0012
841 LYMPHADENOPATHY 42 0.0012
842 MALIGNANT NEOPLASM PROGRESSION 121 0.0012
843 HEPATIC ENZYME INCREASED 80 0.0012
844 THROMBOSIS 94 0.0012
845 NERVOUSNESS 61 0.0012
846 UNEVALUABLE EVENT 88 0.0012
847 TENDONITIS 18 0.0012
848 ILL-DEFINED DISORDER 70 0.0012
849 HYPERSOMNIA 33 0.0011
850 HIP FRACTURE 37 0.0011
851 NIGHT SWEATS 37 0.0011
852 DEAFNESS 30 0.0011
853 CYANOSIS 18 0.0011
854 RASH MACULAR 40 0.0011
855 PRODUCT AVAILABILITY ISSUE 26 0.0011
856 ANAPHYLACTIC REACTION 63 0.0011
857 MOOD ALTERED 31 0.0011
858 NEEDLE ISSUE 33 0.0011
859 DISCOMFORT 69 0.0011
860 THERAPY CESSATION 58 0.0011
861 TRANSAMINASES INCREASED 25 0.0011
862 DISEASE PROGRESSION 133 0.0011
863 UNDERDOSE 82 0.0011
864 SUICIDE ATTEMPT 67 0.0011
865 PAIN IN JAW 31 0.0011
866 FULL BLOOD COUNT DECREASED 22 0.0011
867 BASAL CELL CARCINOMA 17 0.0011
868 HERNIA 21 0.0011
869 DEEP VEIN THROMBOSIS 70 0.0011
870 POOR QUALITY SLEEP 23 0.0011
871 IMPAIRED HEALING 35 0.0011
872 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 18 0.0011
873 PRODUCT PRESCRIBING ISSUE 23 0.0011
874 VIRAL INFECTION 35 0.0011
875 PLASMA CELL MYELOMA 41 0.0010
876 HYPERSENSITIVITY 195 0.0010
877 TOOTHACHE 19 0.0010
878 ABNORMAL BEHAVIOUR 41 0.0010
879 SPEECH DISORDER 54 0.0010
880 IMPAIRED WORK ABILITY 22 0.0010
881 FIBROMYALGIA 25 0.0010
882 ROAD TRAFFIC ACCIDENT 43 0.0010
883 AGITATION 75 0.0010
884 PSORIASIS 133 0.0010
885 RHEUMATOID ARTHRITIS 115 0.0010
886 EYE DISORDER 33 0.0010
887 HEPATIC CANCER 24 0.0010
888 NERVOUS SYSTEM DISORDER 31 0.0010
889 LACRIMATION INCREASED 30 0.0010
890 EXTRA DOSE ADMINISTERED 40 0.0010
891 BLADDER CANCER 58 0.0010
892 BONE PAIN 57 0.0010
893 DEATH 838 0.0010
894 ABASIA 24 0.0010
895 MENTAL DISORDER 42 0.0010
896 DEPRESSION 219 0.0010
897 FEELING HOT 59 0.0010
898 ACTIVITIES OF DAILY LIVING IMPAIRED 19 0.0010
899 ANHEDONIA 25 0.0010
900 LUNG NEOPLASM MALIGNANT 39 0.0009
901 DISEASE RECURRENCE 45 0.0009
902 CARDIOVASCULAR DISORDER 24 0.0009
903 ABNORMAL DREAMS 26 0.0009
904 COLITIS ULCERATIVE 42 0.0009
905 THERAPY INTERRUPTED 67 0.0009
906 LOWER LIMB FRACTURE 18 0.0009
907 BONE DISORDER 17 0.0009
908 OVERDOSE 201 0.0009
909 NEOPLASM MALIGNANT 62 0.0009
910 SKIN CANCER 20 0.0009
911 DRUG INEFFECTIVE 1202 0.0009
912 PSORIATIC ARTHROPATHY 37 0.0009
913 PRODUCT USE IN UNAPPROVED INDICATION 224 0.0009
914 BONE DENSITY DECREASED 28 0.0009
915 GLOSSODYNIA 20 0.0009
916 HOT FLUSH 67 0.0009
917 EPILEPSY 27 0.0009
918 HOSPITALISATION 133 0.0009
919 OCULAR HYPERAEMIA 41 0.0009
920 NEURALGIA 21 0.0009
921 MYELOSUPPRESSION 31 0.0009
922 DISABILITY 17 0.0009
923 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 20 0.0009
924 DRUG RESISTANCE 22 0.0009
925 HAEMORRHAGE 89 0.0009
926 DRY EYE 42 0.0008
927 BONE MARROW FAILURE 17 0.0008
928 RESPIRATORY DISORDER 25 0.0008
929 NEOPLASM PROGRESSION 29 0.0008
930 GASTRIC CANCER 21 0.0008
931 FEAR 22 0.0008
932 DRUG ABUSE 68 0.0008
933 PRODUCT DOSE OMISSION IN ERROR 23 0.0008
934 IRRITABILITY 48 0.0008
935 THERAPEUTIC RESPONSE DECREASED 47 0.0008
936 INTENTIONAL DOSE OMISSION 22 0.0008
937 DRUG EFFECT INCOMPLETE 28 0.0008
938 PRODUCT DOSE OMISSION 50 0.0008
939 MUCOSAL INFLAMMATION 20 0.0008
940 PRODUCT DOSE OMISSION ISSUE 222 0.0008
941 THERAPEUTIC RESPONSE SHORTENED 25 0.0008
942 OSTEONECROSIS OF JAW 18 0.0007
943 MOOD SWINGS 23 0.0007
944 DRUG DOSE OMISSION 119 0.0007
945 DRUG ADMINISTRATION ERROR 22 0.0007
946 INJECTION SITE HAEMORRHAGE 57 0.0007
947 INCORRECT DOSE ADMINISTERED 162 0.0007
948 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 38 0.0007
949 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 49 0.0007
950 JOINT STIFFNESS 18 0.0007
951 SURGERY 40 0.0007
952 THROAT IRRITATION 30 0.0007
953 THERAPY NON-RESPONDER 30 0.0007
954 INFUSION RELATED REACTION 42 0.0006
955 ARTHROPATHY 35 0.0006
956 TREATMENT FAILURE 52 0.0006
957 EYE IRRITATION 36 0.0006
958 THERAPEUTIC PRODUCT EFFECT DECREASED 28 0.0006
959 GYNAECOMASTIA 19 0.0006
960 PRODUCT QUALITY ISSUE 83 0.0006
961 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 122 0.0006
962 INJECTION SITE PRURITUS 40 0.0006
963 INJECTION SITE PAIN 183 0.0006
964 BREAST CANCER 55 0.0006
965 FLUSHING 58 0.0006
966 ANGER 19 0.0006
967 INJECTION SITE SWELLING 42 0.0005
968 RENAL CANCER 26 0.0005
969 INJURY 38 0.0005
970 SKIN IRRITATION 24 0.0005
971 CRYING 18 0.0005
972 VAGINAL HAEMORRHAGE 20 0.0005
973 DEVICE ISSUE 41 0.0005
974 PRODUCT SUBSTITUTION ISSUE 26 0.0005
975 WITHDRAWAL SYNDROME 18 0.0004
976 ADVERSE EVENT 39 0.0004
977 INJECTION SITE BRUISING 33 0.0004
978 SUICIDAL IDEATION 36 0.0004
979 INJECTION SITE ERYTHEMA 48 0.0004
980 PROSTATE CANCER 28 0.0003
981 DRUG EFFECT DECREASED 18 0.0003
982 EMOTIONAL DISTRESS 40 0.0003
983 DEVICE MALFUNCTION 23 0.0003
984 FOETAL EXPOSURE DURING PREGNANCY 26 0.0003
985 NO ADVERSE EVENT 53 0.0003
986 ACCIDENTAL EXPOSURE TO PRODUCT 26 0.0003
987 PRODUCT STORAGE ERROR 22 0.0003
988 ACNE 17 0.0002
989 MATERNAL EXPOSURE DURING PREGNANCY 18 0.0002
990 DRUG DEPENDENCE 20 0.0001